Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+9.6%
5Y CAGR+61.2%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+9.6%/yr
vs +10.7%/yr prior
5Y CAGR
+61.2%/yr
Recent deceleration
Acceleration
-1.1pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
10.9x
Strong expansion
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $72.98M | +5.8% |
| 2024 | $68.95M | +135.5% |
| 2023 | $29.27M | -47.2% |
| 2022 | $55.49M | -36.6% |
| 2021 | $87.53M | +1206.6% |
| 2020 | $6.70M | -70.7% |
| 2019 | $22.89M | -38.1% |
| 2018 | $37.00M | +165.7% |
| 2017 | $13.92M | -19.2% |
| 2016 | $17.23M | - |